Volcano Announces CE Mark and 510(k) Clearance for New Visions® PV .035 Digital IVUS Catheter

Volcano Announces CE Mark and 510(k) Clearance for New Visions® PV .035 Digital IVUS Catheter PR Newswire SAN DIEGO, Oct. 4, 2012 -- New Patent-pending Design Continues Commitment to Treating Peripheral Vascular Disease SAN DIEGO, Oct. 4, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has received clearance to market its new Visions® PV .035 Digital IVUS Catheter in both the US and Europe. The new intravascular ultrasound catheter is designed to image large vessels and facilitate the use of less iodinated contrast in endovascular procedures. Intravascular ultrasound imaging (IVUS) of diseased arteries and veins allows physicians to observe vessel morphology and make real-time measurements that impact treatment strategies and ultimately patient outcomes. The Visions PV .035 catheter incorporates new centimeter markers to facilitate length measurements important for selecting treatment devices. "Endovascular repair is preferred over open surgical repair by many patients because of its less invasive nature, shorter recovery times and lower complication rates for patients with suitable anatomy," said David Sheehan, chief operations officer and intravascular imaging business unit leader. "However, precise device sizing and placement is critical for positive outcomes[1].